Skip to main content
. 2012 Jun 23;62(1):27–37. doi: 10.1007/s00262-012-1303-8

Fig. 1.

Fig. 1

IFN-gamma ELISpot spot counts per 5 × 104 T cells for tumor-infiltrating (a) and peripheral (b) T cell samples from representative MSI-H and MSS CRC patients as well as one healthy donor. Bars represent mean spot numbers ± standard deviation. Significant elevated spot numbers compared to the negative control are marked with asterisk